Oxcarbazepine Tablet, Film Coated
Product Images NDC 63629-9186

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 63629-9186). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636299186)

This is a medication bottle label that contains Oxcarbazepine tablets, USP. Each film-coated tablet contains 300 mg of Oxcarbazepine. The recommended dosage is available on the insert. This medication should be kept out of reach of children and stored at a controlled temperature range of 20°-25°C (77°F). It contains FD&C Yellow No. 5 as a color additive and should be dispensed in a tight container. This is a prescription drug and should be dispensed with a medication guide for each patient. The NDC code for this medication is 63629-9186-01.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

FDA Label Image

Figure 1 (Oxcarbazepine 02)

The text is providing information regarding the Exit Rate and log-rank test p-value with a graph showing the variation with time on trial. The study includes a Placebo group, and the graph shows the Exit Rate and time on trial from Day 2 to Day 11.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

This is a data table showing the days from the first dose to the first seizure of two treatment groups - Oxcarbazepine and Placebo. The Seizure Rate was tested using a log-rank test and yielded a p-value of 0.046.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

FDA Label Image

Figure 4 (Oxcarbazepine 05)

This appears to be a survival analysis output chart showing the exit rate and time to exit in days for a treatment group compared to a control group. The log-rank test was performed and the p-value is 0.0001, indicating a statistically significant difference between the groups. The chart displays time intervals from 10 to 130 days and specifies that the treatment group is labeled "HIGH" and the control group is labeled "LOW".*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.